Further to DrugAlert Volume 164, HPS Pharmacies are pleased to advise that Link Healthcare have given notice of the successful TGA authorisation of:
Carbimazole ARISTO® 5mg tablets
The authorisation for distribution is under Section 19(A) of the Therapeutic Goods Act, which permits supply of an unregistered product, in situations where there is an interruption to supply of a registered product for which there is a recognised medical need.
Although Carbimazole ARISTO® is not registered, it does not require Special Access Scheme approval for supply, and will be included onto the PBS from 1st December, 2014.
Link Healthcare will supply Carbimazole ARISTO® tablets until the availability of Neo Mercazole® (carbimazole) 5mg tablets, ARTG 194296 returns to normal, which is not expected until 2014.
HPS Pharmacies will continue to notify of changes in availability as we are made aware. Please retain this notice in a prominent position, including other related business units as a reminder for all staff members until supply returns to normal.
Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please do not hesitate to contact your pharmacist at HPS Pharmacies or Link Healthcare Customer Service on 1800 181 060.
Information regarding expected dates for supply may vary subject to delays which are out of our control. HPS Pharmacies does not accept responsibility for such changes but will endeavour to keep our clients updated as information is made available from drug manufacturers or wholesalers.